Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Pei DongXinyue ZhangYu-Lu PengYijun ZhangRuiqi LiuYilin LiQiwen PanWen-Su WeiSheng-Jie GuoZhiling ZhangHui HanFang-Jian ZhouYang LiuLiru HePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Immune infiltration is frequent in FHRCC. ICI-based treatment is a promising regimen, and treatment response depends on the functional status of tumor-infiltrating lymphocytes. ICI-based treatment cannot reverse the exhaustion of CD8+ T cells in patients with progressive disease, highlighting the need for additional therapeutic strategies.